Hypofractionated-intensity Modulated Radiotherapy (Hypo-Imrt) and Temozolomide (TMZ) with or Without Bevacizumab (BEV) for Newly Diagnosed Glioblastoma Multiforme (GBM): a Comparison of Two Prospective Phase II Trials
International Journal of Radiation OncologyBiologyPhysics（2014）
关键词
Glioblastoma multiforme,GBM,Intensity modulated radiation therapy,Bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要